Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:59 AM
Ignite Modification Date:
2025-12-26 @ 10:59 AM
NCT ID:
NCT04637906
Eligibility Criteria:
Inclusion Criteria:
* age\> 18 years
* Diagnosis of COVID 19, confirmed by RT-PCR on a nasopharyngeal swab
* COVID 19 pneumonia with the following clinical characteristics: SpO2 in ambient air \<93% and Alveolar pressure of oxygen / inspiratory fraction of oxygen (PaO2 / FiO2 - P / F \<300 mmHg.
* Lymphocytopenia defined as lymphocytes \<1500 / mcL or \<20% of white blood cells
Exclusion Criteria:
* History of intolerance to L-arginine
* Severe chronic pulmonary disease
* Pregnancy or breastfeeding
* Neutropenia due to neoplasms of the haematopoietic system or other organs with invasion of the bone marrow
* Use of immunosuppressive drugs or cytotoxic chemotherapies within the previous three weeks
* Refusal to give consent to participate in the study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
19 Years
Study:
NCT04637906
Study Brief:
Protocol Section:
NCT04637906